Search
Marine collagen, soluble
go.drugbank.com/drugs/DB14246InvestigationalMarine collagen, soluble is an animal extract used in some OTC (over-the-counter) products. It is not an approved drug.
Allocetra
go.drugbank.com/drugs/DB16424InvestigationalAllocetra is a novel therapy where billions of early apoptotic cells are infused into the bloodstream of a patient, using the body's own natural regulation mechanisms to rebalance an unbalanced immune … With infusion, the body's macrophages and dendritic cells can feed on these early apoptotic Allocetra cells and thus result in the macrophages and dendritic cells releasing fewer cytokine alert signals
Sus scrofa placenta
go.drugbank.com/drugs/DB14243InvestigationalSus scrofa placenta is an animal extract used in some OTC (over-the-counter) products. It is not an approved drug.
Ostrea edulis shell
go.drugbank.com/drugs/DB14251InvestigationalOstrea edulis shell is an animal extract used in some OTC (over-the-counter) products. It is not an approved drug.
Topsalysin
go.drugbank.com/drugs/DB05160InvestigationalTopsalysin is being developed for the treatment of localized prostate cancer and also benign prostatic hyperplasia. Topsalysin is delivered locally to the prostate under ultrasound guidance.
Large ribosomal subunit protein uL16
go.drugbank.com/bio_entities/BE0009104TargetHumansMay play a role in the embryonic brain development (PubMed:25316788)
Synonyms: Laminin receptor homologKB109
go.drugbank.com/drugs/DB16531ExperimentalKB109 is a prebiotic to feed healthy bacteria for them to to outcompete multi-drug resistance organisms.
PARPI F-18
go.drugbank.com/drugs/DB18657ExperimentalPARPI F-18 is a diagnostic agent under investigation for use in the management of glioblastoma multiforme.
Canvuparatide
go.drugbank.com/drugs/DB18658InvestigationalCanvuparatide is a long-acting parathyroid hormone peptide prodrug under investigation for the treatment of hyperparathyroidism.[L48365]
Ivonescimab
go.drugbank.com/drugs/DB18931InvestigationalIvonescimab is under investigation in clinical trial NCT05184712 (Phase 3 Clinical Study of AK112 for NSCLC Patients).